Roche: Perjeta verlängert das Leben von Patientinnen mit einer aggressiven Form von metastasierendem Brustkrebs
- 0 minute read
You May Also Like
- Cardiovascular risk and obesity
Pathomechanisms, secondary prevention and treatment options
- Oxidative stress and neurodegeneration
Insights and therapeutic strategies for Parkinson’s disease
- Biologics for atopic dermatitis
Th2 cytokines in focus: proven and new targets
- Teens, Screen and Mental Health
How social media influences depression in young people
- CHD: Management after revascularization
Individualization of antithrombotic therapy
- Chemsex - MSM, sex, chrystal meth & co.
Medical and psychosocial perspectives
- Liver steatosis with metabolic dysfunction
New nomenclature for non-alcoholic fatty liver disease
- IBDmatters - Advanced Therapeutic Treatments